Juan Jesús
Gómez-Reino Carnota
Karolinska Institute
Estocolmo, SueciaPublicacións en colaboración con investigadores/as de Karolinska Institute (8)
2019
-
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1536-1544
2017
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 960-977
-
Rituximab retreatment in rheumatoid arthritis in a real-life cohort: Data from the CERERRA collaboration
Journal of Rheumatology, Vol. 44, Núm. 2, pp. 162-169
2016
-
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration
Arthritis Research and Therapy, Vol. 18, Núm. 1
-
Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration [Arthritis Res Ther. 18: (2016); 50], doi: 10.1186/s13075-016-0951-z
Arthritis Research and Therapy
-
Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search update
Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 16-22
2014
-
Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis
Arthritis Research and Therapy, Vol. 16, Núm. 4
2010
-
The Eular recommendations for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs
Rheumatologia, Vol. 24, Núm. 4, pp. 143-158